Brachytherapy
Volume 6, Issue 4 , Pages 231-237 , October 2007

Intraoperative adaptive brachytherapy of iodine-125 prostate implants guided by C-arm cone-beam computed tomography–based dosimetry

  • Hendrik Westendorp

      Affiliations

    • Department of Medical Physics, Radiotherapeutic Institute RISO, Deventer, The Netherlands
    • Department of Radiation Oncology, Radiotherapeutic Institute RISO, Deventer, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Medical Physics, Radiotherapeutic Institute RISO, PO Box 123, 7400 AC, Deventer, The Netherlands. Tel.: +31-570-646900; fax: +31-570-646901.
  • ,
  • Carel J. Hoekstra

      Affiliations

    • Department of Radiation Oncology, Radiotherapeutic Institute RISO, Deventer, The Netherlands
  • ,
  • Arie van't Riet

      Affiliations

    • Department of Medical Physics, Radiotherapeutic Institute RISO, Deventer, The Netherlands
    • Department of Radiation Oncology, Radiotherapeutic Institute RISO, Deventer, The Netherlands
  • ,
  • André W. Minken

      Affiliations

    • Department of Medical Physics, Radiotherapeutic Institute RISO, Deventer, The Netherlands
    • Department of Radiation Oncology, Radiotherapeutic Institute RISO, Deventer, The Netherlands
  • ,
  • Jos J. Immerzeel

      Affiliations

    • Department of Radiation Oncology, Radiotherapeutic Institute RISO, Deventer, The Netherlands

Received 25 May 2007 ,Revised 15 August 2007 ,Accepted 21 August 2007.

References 

  1. Mueller A, Wallner K, Merrick G, et al. Modification of prostate implants based on postimplant treatment margin assessment. Med Phys. 2002;29:2782–2787
  2. Ash D, Al-Qaisieh B, Bottomley D, et al. The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer. Radiother Oncol. 2006;79:185–189
  3. Stock RG, Stone NN, Tabert A, et al. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys. 1998;41:101–108
  4. Nag S, Bice W, DeWyngaert K, et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 2000;46:221–230
  5. Keyes M, Pickles T, Agranovich A, et al. 125I reimplantation in patients with poor initial dosimetry after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004;60:40–50
  6. Zelefsky MJ, Zaider M. Low-dose-rate brachytherapy for prostate cancer: Preplanning vs. intraoperative planning-intraoperative planning is best. Brachytherapy. 2006;5:143–144[Discussion 146]
  7. Han BH, Wallner K, Merrick G, et al. Prostate brachytherapy seed identification on post-implant TRUS images. Med Phys. 2003;30:898–900
  8. Steggerda M, Schneider C, van Herk M, et al. The applicability of simultaneous TRUS-CT imaging for the evaluation of prostate seed implants. Med Phys. 2005;32:2262–2270
  9. Gong L, Cho PS, Han BH, et al. Ultrasonography and fluoroscopic fusion for prostate brachytherapy dosimetry. Int J Radiat Oncol Biol Phys. 2002;54:1322–1330
  10. Todor DA, Zaider M, Cohen GN, et al. Intraoperative dynamic dosimetry for prostate implants. Phys Med Biol. 2003;48:1153–1171
  11. Su Y, Davis BJ, Herman MG, et al. Prostate brachytherapy seed localization by analysis of multiple projections: Identifying and addressing the seed overlap problem. Med Phys. 2004;31:1277–1287
  12. Fuller DB, Jin H, Koziol JA, et al. CT-ultrasound fusion prostate brachytherapy: A dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases. Brachytherapy. 2005;4:207–216
  13. Kaplan ID, Meskell P, Oldenburg NE, et al. Real-time computed tomography dosimetry during ultrasound-guided brachytherapy for prostate cancer. Brachytherapy. 2006;5:147–151
  14. Reed DR, Wallner KE, Narayanan S, et al. Intraoperative fluoroscopic dose assessment in prostate brachytherapy patients. Int J Radiat Oncol Biol Phys. 2005;63:301–307
  15. Holm HH, Juul N, Pedersen JF, et al. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol. 1983;130:283–286
  16. Nag S, Beyer D, Friedland J, et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 1999;44:789–799
  17. Taussky D, Austen L, Toi A, et al. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT–MRI fusion. Int J Radiat Oncol Biol Phys. 2005;62:974–980
  18. Prestidge BR, Bice WS, Kiefer EJ, et al. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;40:1111–1115
  19. Waterman FM, Yue N, Corn BW, et al. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: An analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys. 1998;41:1069–1077
  20. Xue J, Waterman F, Handler J, et al. Localization of linked 125I seeds in postimplant TRUS images for prostate brachytherapy dosimetry. Int J Radiat Oncol Biol Phys. 2005;62:912–919
  21. Chauveinc L, Flam T, Solignac S, et al. Prostate cancer brachytherapy: Is real-time ultrasound-based dosimetry predictive of subsequent CT-based dose distribution calculation? A study of 450 patients by the Institut Curie/Hospital Cochin (Paris) Group. Int J Radiat Oncol Biol Phys. 2004;59:691–695
  22. Al-Qaisieh B, Ash D, Bottomley DM, et al. Impact of prostate volume evaluation by different observers on CT-based post-implant dosimetry. Radiother Oncol. 2002;62:267–273
  23. Smith WL, Lewis C, Bauman G, et al. Prostate volume contouring: A 3D analysis of segmentation using 3DTRUS, CT, MR. Int J Radiat Oncol Biol Phys. 2007;67:1238–1247
  24. Salembier C, Lavagnini P, Nickers P, et al. Tumour and target volumes in permanent prostate brachytherapy: A supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol. 2007;83:3–10
  25. Westendorp R, van't Riet A, Bouwman R, et al. Assessment of prostate volume determining parameters in I-125 therapy. Radiother Oncol. 2004;71:S4

PII: S1538-4721(07)00244-9

doi: 10.1016/j.brachy.2007.08.005

Brachytherapy
Volume 6, Issue 4 , Pages 231-237 , October 2007